Ok lor continue your delusions. Christmas time then we see

GenS Q1 net profit was $247m, Q2 net profit dropped by 55% to $109m. These are facts. Nothing insinuating. Cannot take facts in this forum ah? Have to only listen to your crystal ball?

3 days ago | Report Abuse

Posted by Michaelchan2024 > 3 hours ago | Report Abuse
SGD 500 million for Q2! This is massive!
-----------

All kena conned. Its way off la... Q2 NP= S$109m 🤣🤣🤣
*************

I was laughing at @MC'S delusion 🤣🤣🤣

Posted by AngTayKor > 2 days ago | Report Abuse

ATK a ghost or not you decide lor. Hope some traders / trader cum investors here have read and exited promptly near the 5.20 top.

Then buy again at around 4.50 zone, exit at around 4.8+ zone.
Then buy again at around 4.50 zone, exit at around 4.8+ zone.
Then buy again at around 4.20 zone, exit at around 4.50 zone.

Its not difficult to trade this stock. 
--------------

Posted by AngTayKor > 1 day ago  | Report Abuse

I have never shorted a single GenB stock. Better watch the stock's price action, the market is already whispering something now....
-----------------


Later this month we see the price again.

Posted by mushimushi > 2 days ago | Report Abuse

Tomorrow 4.8
-----------


The crowd has very short term memory. Who is the scammer here ah?

The stubborn ones who refuse to learn + continue baseless attacks against good sharings, let the market teach them the lessons. Look at your own trading / investment P&L for this stock. Is it showing green or red?

Well said @Balian. Very professional crowd psychology explanation 👏

Please dont be humble @Balian. Do speak up n share your knowledge. Many readers here including ATK always willing to learn.

Indeed 此地高手如云，藏龙卧虎，深藏不露 👍

Trader has already given his views on the next price direction if you have read his posts carefully over the past couple of days.

Ditto

For you @Balian:

https://youtu.be/yL9rSwrsMHw?si=BJy9Y-pvp6O2OA8b

You are really very funny @Balian!!! 🤣🤣🤣

Could be possible also 🤔

Immediately predict 5.10, Immediately price collapsed to 4.17. It is real. No excuses please.

You might as well predict GenB rm20.00? Eventually when 10th generation Lim takes over, may even become a rm100.00 stock.

Aiya, a dead clock will still be right twice a day n claim he is correct. Bingo!

The real skill is immediately buy immediately huat, Immediately sell immediately price collapse.

Posted by AngTayKor > 2024-03-11 16:18 | Report Abuse
New data presentation on 7/3 at local time 8.50am. Not regulatory approvals yet.
Reminder: Regulatory approvals not so soon yet. Still got hurdles to cross especially the corrupted FDA.
-------------
Posted by AngTayKor > 2024-03-11 18:36 | Report Abuse
Please remember history lesson becareful of 5.20 zone LKT waiting to dump. Price action of afternoon session dont look good.
--------------
Posted by Michael_chan2022 > 2024-03-12 11:34 | Report Abuse
Be careful. Another short squeeze in the afternoon
-----------
Posted by AngTayKor > 2024-03-12 11:46 | Report Abuse
Unlikely
------------
Posted by keyman > 2024-03-12 12:19 | Report Abuse
Sifu @Balian @micheal @ATK@neoths All say downward is unlikely. How am I catch the boat now? Sold 4.85 then buy back 4.97 loss 10 cents leh...
------------
Posted by AngTayKor > 2024-03-12 14:09 | Report Abuse
Read clearly. I said whales exited yesterday

-----------
Posted by Michael_chan2022 > 2024-03-12 12:11 | Report Abuse

https://youtu.be/dIazk_tO1D0?si=Bc7cep0R3VvMENSg
Real sifu is here,
GenB strong support at RM4.98

**************

---------------------------------------------------
PRICE COLLAPSED TO 4.44 ONE MONTH LATER
==============================


加多一句: 记住: 此地高手如云，藏龙卧虎，深藏不露

加多一句: 记住: 此地高手如云，藏龙卧虎，深藏不露..


旧战国:
4.20 - 4.00 - 5.00
4.65 - 4.45 - 4.95
4.95 - 4.55 - 4.87

新战国: 4.87 - 4.65 - 5.10
-------------


4.87 - 4.65 - 5.10 (Crystal ball not working)

*****************************
PRICE COLLAPSED TO 4.17
*****************************

Lyrics for the Music Video. @MC can sing n rap along. Jealousy...

Posted by Michaelchan2024 > 5 hours ago | Report Abuse
ATK often insists he’s not invested in Genting, yet he remains active in the forum for years, arguing and bullying investors online. His claims are met with skepticism, and his negative attitude exacerbates mistrust and frustration among members. This behavior may be intended to stir up conflict and promote his personal agenda, leading to a highly strained and contentious environment. Such actions might be seen as characteristic of a low-class investor, given the disruptive nature of his approach.
-------------


You posted too much rubbish here. @mushi has much less posts. Check thru his recent records see who started attacking n online bullying first.

I can't tell you why these things continue to happen to me
But some people get so jealous of the smallest of all things
I tried to help some friends, to help themselves
To get their lives intact
They came out spreading rumors
Now I have to come out spreading facts

Let me tell how this started
And where it all began
I guess I was a fool to try and help my broken social friends
They told me if I'd help them, they'd be in debt for life
But when I turned my back to get support
They stabbed me with a knife, oh no

I don't need jealousy (No)
I don't want the bad talk around me
I don't need jealousy (Oh)
I don't want the bad talk around me

You came out spreading rumors
Because you were so jealous
You didn't understand that we were on your side, tell me why not, fellas?
You let some people guide you in the wrong direction
From the truth you cannot hide, so don't go look for no protection
I didn't understand it then, and you know I just can't now
You know I tried to help you out and now it's me you're trying to clown
But let me tell you, partner
You won't come out ahead
All this jealousy will do is make you lose it all instead, oh no

I don't need jealousy
I don't want the bad talk around me
I don't need jealousy
I don't want the bad talk around me

Jealous folks cause trouble
Yapping all the time
You know they're listening for rumors so that they can drop a dime
They run from place to place
Just telling half the story
Because they're always trying to down someone and take their fame and glory
If it hasn't happened to you, just give yourself some time
I think you know the symptoms when a jealous person drops a line
I think I'll write a letter that sums it up the best
I'll have to write it in big letters
With my business, please don't mess, oh no

I don't need jealousy (I don't need no jealousy)
I don't want the bad talk around me
I don't need jealousy
I don't want the bad talk around me

I don't need jealousy
I don't want the bad talk around me
I don't need jealousy
I don't want the bad talk around me

I don't need, you don't need, we don't need no jealousy
I don't need, you don't need, we don't need no jealousy
I don't need, you don't need, we don't need no jealousy
I don't need, you don't need, we don't need no jealousy

I don't need jealousy
I don't want the bad talk around me
I don't need jealousy
I don't want the bad talk around me

The number 1 reason for attacking Balian:

Bought high, stuck high, became involuntary long term investor, blaming others whenever share price pulls back.

Those with the real skill to make money from the stock market n have the confidence to do it repeatedly, will often attract detractors attacking him out of jealousy.

Good morning Michael!

https://youtu.be/lKWhkjXV5uM?si=XPJW4sqA-UnNRA0q

Posted by mushimushi > 4 hours ago | Report Abuse
Actually got demand for Balian and ATK's IP addresses honestly.
------------

Why all the ATK bashing again? Im not a GenB shortie, I calculated GenS Q2 net profit for those who were unsure abt the figure and I share my views as an experienced stock trader.

It is always very easy to blame the shorties, blame LKT, blame everyone else except to blame ourself. The first step to real learning and improvement is to take FULL responsibility for our own trades / investments.

Got demand for Taurx news leh.... even from those who think Taurx is just an illusion.

2 weeks ago | Report Abuse

Posted by Michaelchan2024 >| Report Abuse
ATK, following validation, the MHRA aims to complete the detailed assessment within 150 days. So we should know the outcome by Dec 2024, right?
-----------

Hopefully the best Christmas present for all Genting & Taurx shareholders 😀😀

Dont blame Taurx news for retail punters' misfortunate. When Maybank etc analysts recommend buy, its often too late to buy liow (Johnny-come-late syndrome). Retail punters' human nature, greed n behaviour never change generation after generation. Cannot blame Taurx / Maybank IB/ etc when punters like to buy near resistance zones n sell near support zones.

Posted by Michaelchan2024 > 3 weeks ago | Report Abuse

After over 10 years in this forum, besides trading and conning retailers with TauRx news, ATK truly has nothing else to share.
-----------


So who is conning retailers with a fake crystal ball here ah??? 🤣🤣🤣

I have never endorsed those measurements since day 1. Confirm not mine la.

Posted by Michaelchan2024 > 11 hours ago | Report Abuse
旧战国:
4.20 - 4.00 - 5.00
4.65 - 4.45 - 4.95
4.95 - 4.55 - 4.87
新战国:
4.87 - 4.65 - 4.18 - 4.50 - (5.50)?
-------------

Oh no.... please dont do this again.... your crystal ball has been a good reverse indicator

旧战国:
4.20 - 4.00 - 5.00
4.65 - 4.45 - 4.95
4.95 - 4.55 - 4.87

新战国: 4.87 - 4.65 - 5.10
-------------


4.87 - 4.65 - 5.10 (Crystal ball not working)

*****************************
PRICE COLLAPSED TO 4.17
*****************************

Posted by Michaelchan2024 > 1 day ago | Report Abuse
Genting Singapore had a great performance today with a strong finish.. tomorrow it's GenB’s turn, get ready for the ride! 👍
--------
Posted by AngTayKor > 1 day ago | Report Abuse

Please stop guessing la. You usually got it wrong most of the time, becoming an inverse indicator.
------------


Please la @MC for the sake of all investors here dont kill the share price by using your crystal ball again.

Posted by mushimushi > 36 minutes ago | Report Abuse
Wondering if i3 can provide IP address of Koutouan (bitcoin investment scammer), see if same with any of the shorties here like Balian and ATK. I3 can help investigate?
--------------

I have never shorted a single GenB stock. Better watch the stock's price action, the market is already whispering something now....

Posted by AngTayKor > 1 month ago | Report Abuse

Posted by Michaelchan2024 > | Report Abuse
ATK's peculiar behavior is that he always tends to tell people to sell, which is typical of short sellers..
--------------

Its all in your mind @Michael. When Im talking history events like past RPTs, LKT sold huge volumes above 5.20 or some occasional negative things, perma bulls will think that Im preaching for everyone to sell. The crowd forgets things very quickly including my bullish Q1 profit forecast of rm600m before the actual Q1 result. They often will choose to retain info according to the state of their fickle mind. To set the record straight, I have never shorted a single stock of GenB. I depend on my own charting skills to trade. I think it is naive to think that posting fear mongering / super bullish posts here in i3 will influence the stock price.

Better watch Q2 result later this month. I see you & @MC both predicting Net Profit of rm500m.

Many in the past have accused ATK a fake horse-back-cannon trader. Then i posted my real trading records. For this time @mushi i have no trading records for you because there has been no trading transactions for a long time liow. I do have some taurx share purchases recently but these transactions are not done electronically that can easily cut n paste to post.

Posted by mushimushi > 19 minutes ago | Report Abuse
ATK used to be very positive about Genting, why suddenly changed of tone? He sold all during recent black Monday at the lowest price?
-----------

Please la since when im very negative abt GenB? Im posting some Tau news which there are many non-believers here. They scared GenB holding a chow taofu.

Research on Taofu in the AD field is getting very fashionable now. Mab drugs are giving so little symptomatic returns with so high risk including deaths and permanent severe brain injuries, at a very high cost + lack of medical infrastructure and trained personnel to roll out Mab drugs.

Posted by AngTayKor > 4 weeks ago | Report Abuse

Alzheimer's biotech Asceneuron raises $100M to see if it can compete with Lilly, Biogen on tau

A small Swiss biotech has raised a $100 million Series C to start testing its oral small molecule for Alzheimer’s disease in a Phase 2 later this year.

Asceneuron, a Merck KGaA spinout, is developing the O-GlcNAcase (OGA) inhibitor ASN51 and is hoping to go up against the two leading drugmakers in the Alzheimer’s field: Eli Lilly and Biogen.

The 12-year-old biotech started raising the Series C around the beginning of the year, CEO Barbara Angehrn Pavik said in an interview. She joined last fall after helping Vifor exit to CSL for $11.7 billion as chief business officer. Asceneuron was light on specifics of the Phase 2 trial design, including whether it’d be a global study.

Led by Novo Holdings, the Series C is expected to fully fund the trial and potentially see whether ASN51 can be developed for additional conditions, including Parkinson’s and amyotrophic lateral sclerosis, according to new board member Naveed Siddiqi, a senior partner on the venture investments team at Novo Holdings.

In addition to Novo Holdings, other investors in the Series C include new backers EQT Life Sciences’ LSP Dementia Fund, OrbiMed and SR One, along with existing financial supporters M Ventures, Sofinnova Partners, GSK Equities Investments and Johnson & Johnson Innovation’s JJDC.
Race with Lilly, Biogen

Biogen and Lilly are also developing their own experimental medicines aiming to inhibit the OGA enzyme with the goal of slowing down or curbing the buildup of tau protein.

Biogen and Lilly’s current marketed drugs — Leqembi and Kisunla, respectively — go after the pesky protein amyloid. But their new medicines, alongside Asceneuron, seek to destroy tau. The neurodegenerative-linked protein comes after amyloid and can damage neurons upon accumulation.

Lilly is in the lead on the OGA front, with a Phase 2 of its drug LY3372689 estimated to wrap up this summer, according to the federal trials database. Biogen’s candidate, named BIIB113, completed a Phase 1 last year. Multiple other drugmakers are developing anti-tau treatments with different approaches.

Leqembi was approved in 2023, but has had a slow commercial rollout, and Kisunla secured FDA approval last month after multiple delays over the past year. These anti-amyloid drugs have to be infused, which can be a strain on healthcare systems and can cause logistical hurdles for patients, and they’ve come with safety concerns about brain swelling and bleeding.

“The infrastructure and cost of this is enormous, so what the field really needs is an oral, a pill, you could take at home. And what we picked up was that there is a new class coming through of OGA inhibitors, which Lilly, Biogen and Asceneuron are developing,” Siddiqi said.

“Lilly will hopefully validate this class later on this year, and then we are second after that in a very large market,” Siddiqi said. He said it’s believed that tau is “more highly correlated with the loss of your cognition than amyloid is.”

The field has been trying to tackle tau for years. Lilly, Biogen, Roche, AbbVie and others have attempted anti-tau approaches with monoclonal antibodies, but none of them panned out in key clinical studies. “If you want an efficacious tau-targeting approach or therapy, it really is going to need to influence the aggregation of tau inside the cell,” Asceneuron SVP of R&D Ryan Schubert said.
----------------------


Treatment aiming to inhibit the OGA enzyme with the goal of slowing down or curbing the buildup of tau protein is not working. I think this type of drug action hungkan liow.

Lilly’s anti-tau pill for Alzheimer’s fails in Phase 2 study

One month after the long-awaited approval of its first Alzheimer’s drug, Eli Lilly said that another experimental medicine aimed at slowing dementia failed in a Phase 2 study of 330 people.

The drug, known as an OGA inhibitor, was designed to prevent a protein called tau from clumping in the brain. Tau often builds up after amyloid plaques — the target of Lilly’s recently approved Kisunla — have formed. Tau proteins are believed to play a bigger role in the death of brain cells.

In the company’s earnings call with investors on Thursday morning, chief scientific officer Dan Skovronsky said that both low and high doses of the drug “failed to meet the primary endpoint” on Lilly’s own scale measuring cognitive decline. Lilly plans to present detailed results at the Clinical Trials on Alzheimer’s Disease conference, which begins in late October.

But Skovronksy emphasized that Lilly isn’t giving up on developing new tau-targeting drugs altogether. “While this negative outcome was disappointing, we remain committed to tau as a high conviction target in Alzheimer’s disease and plan to continue studying tau biology,” he said.

nies working on their own OGA inhibitors. Biogen is testing its own pill in a Phase 1 study. And the Swiss biotech Asceneuron last month raised $100 million to test an OGA inhibitor in a Phase 2 study.

In the run-up to the approval of Kisunla, the Indianapolis drugmaker has increasingly discussed a future where amyloid-busting and tau-lowering drugs are paired together for greater effect. Its OGA inhibitor was especially exciting, because as a pill, it could be a more accessible alternative to Kisunla, which requires monthly infusions and repeated brain scans to monitor for side effects.

The pill inhibits an enzyme called O-GlcNAcase, or OGA, that chemically alters tau proteins and makes them more prone to form toxic tangles that kill brain cells. In an interview with Endpoints News last month, Mark Mintun, Lilly’s VP of neuroscience research and development, downplayed the molecule’s chances of success.

"The OGA inhibitor does a really remarkable job in the animals. But it does it in a very indirect way,” he said. “If we designed something that attacked the tau itself or attacked the tau tangles themselves, we might feel really confident that this is going to work in humans.”

“We joke that we’ve cured Alzheimer’s in mice a lot of times,” Mintun added. “A lot of things just don’t translate to the human Alzheimer’s condition. And we will not be surprised if this is one of those things that doesn’t translate. We feel like we have to try it.”

Lilly has previously tried targeting tau directly with an antibody drug, which failed. Mintun said the company is working on another small molecule that targets tau directly inside brain cells, and a genetic medicine that uses an siRNA to prevent brain cells from making tau in the first place.

In an interview with Endpoints last August, Skovronksy compared tau drugs to the decades-long efforts to attack amyloid in many different ways. “It’s a bit like amyloid,” he said. “We have such conviction on the target, we’re willing to attack it from different mechanisms until we find the mechanism that can actually affect the target. I know that feels stubborn, but to us it just feels logical.”

Posted by Pinky > 2 hours ago | Report Abuse
If buy GENM, GENS results you got no share
I want GENS+GENM
------------

Buy both la at 50:50. You not scared GenB's chow taofo meh?

@Choysun you expect you son-in-laws to adopt your surname meh? Dont la... 🤣

@Choysun, not that im biased sexism but because all descendants still bearing the Genting / RW surname even after having their own family, kids, grandkids etc. 😀

Posted by Michaelchan2024 > 27 minutes ago | Report Abuse
Ho ho ho... my GenM did well today too. Strong closing! 😄
-----------

Good to see investors hedging their bets between mother n sons. The mother seems to be unable to get all her sons to behave well all at once. Q1 Singapore son behaved well but Malaysia son misbehaved. Q2 the Singapore son not behaving as expected but i think Malaysia son shd be good. Adopted son Christmas season report card will be out.

Maybe you shd consider switch horse all into GenM to avoid the Taurx illusion?

Dont worry Im sure a lot of people dont bother to read your posts or take them seriously anyway. Its social media after all kena conned here quite common la.

Please stop guessing la. You usually got it wrong most of the time, becoming an inverse indicator.

ATK a ghost or not you decide lor. Hope some traders / trader cum investors here have read and exited promptly near the 5.20 top.

Then buy again at around 4.50 zone, exit at around 4.8+ zone.
Then buy again at around 4.50 zone, exit at around 4.8+ zone.
Then buy again at around 4.20 zone, exit at around 4.50 zone.

Its not difficult to trade this stock. I started buying when price was 2.97. When I stopped trading this stock long time ago, i think its equivalent to profit of selling the stock at over 8.00.

Posted by AngTayKor > 2024-03-11 16:18 | Report Abuse
New data presentation on 7/3 at local time 8.50am. Not regulatory approvals yet.
Reminder: Regulatory approvals not so soon yet. Still got hurdles to cross especially the corrupted FDA.
-------------
Posted by AngTayKor > 2024-03-11 18:36 | Report Abuse
Please remember history lesson becareful of 5.20 zone LKT waiting to dump. Price action of afternoon session dont look good.
--------------
Posted by Michael_chan2022 > 2024-03-12 11:34 | Report Abuse
Be careful. Another short squeeze in the afternoon
-----------
Posted by AngTayKor > 2024-03-12 11:46 | Report Abuse
Unlikely
------------
Posted by keyman > 2024-03-12 12:19 | Report Abuse
Sifu @Balian @micheal @ATK@neoths All say downward is unlikely. How am I catch the boat now? Sold 4.85 then buy back 4.97 loss 10 cents leh...
------------
Posted by AngTayKor > 2024-03-12 14:09 | Report Abuse
Read clearly. I said whales exited yesterday

-----------
Posted by Michael_chan2022 > 2024-03-12 12:11 | Report Abuse

https://youtu.be/dIazk_tO1D0?si=Bc7cep0R3VvMENSg
Real sifu is here,
GenB strong support at RM4.98

**************

---------------------------------------------------
PRICE COLLAPSED TO 4.44 ONE MONTH LATER
==============================

Posted by Pinky > 2 hours ago | Report Abuse
A stock market investor/trader who only trades Genting and nothing else, based on his activity in i3.
Only lunar month ghost will believe he's not here with an agenda.
Period.
----------

@Pinky I have previously answered this question many times already.